ProfileGDS5822 / ILMN_2846821
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 16% 39% 44% 49% 49% 41% 24% 9% 18% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 111.716
GSM1276600PDAC Late Ablation Control 219.939
GSM1276601PDAC Late Ablation Control 316.544
GSM1276602PDAC Late Ablation 119.149
GSM1276603PDAC Late Ablation 222.449
GSM1276604PDAC Late Ablation 319.941
GSM1303940PDAC Late Ablation_anti-CTLA4 113.924
GSM1303941PDAC Late Ablation_anti-CTLA4 26.39
GSM1303942PDAC Late Ablation_anti-CTLA4 39.718